Iovance Biotherapeutics Balance Sheet (2010-2026) | IOVA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)	58.59M	78.23M	92.36M	108.08M	118.37M	231.73M	543.48M	230.00M	267.70M	114.89M	134.19M	228.68M	164.19M	115.69M	171.67M	132.50M	158.10M	163.08M	196.51M	110.80M
Short-term Investments (Quarter)	517.90M	426.18M	389.80M	316.40M	241.81M	240.11M	82.81M	20.90M	93.65M	164.98M	222.01M			208.09M	188.04M	168.70M	142.70M	133.90M	116.94M	186.91M
Cash & Current Investments (Quarter)	576.49M	504.41M	482.16M	424.48M	360.17M	471.85M	626.29M	250.90M	361.35M	279.87M	356.19M	228.68M	164.19M	323.78M	359.71M	301.20M	300.80M	296.98M	313.44M	297.71M
Receivables - Net (Quarter)								0.03M		0.15M	0.23M	31.60M	55.77M	69.34M	70.94M	59.94M	66.76M	82.45M	81.76M	102.12M
Receivables - Other (Quarter)
Receivables (Quarter)								0.03M		0.15M	0.23M	31.60M	55.77M	69.34M	70.94M	59.94M	66.76M	82.45M	81.76M	102.12M
Raw Materials (Quarter)											5.57M			27.74M	37.91M
Work In Process (Quarter)								8.59M	4.30M	5.75M	5.91M			8.77M	12.09M
Finished Goods (Quarter)								1.13M	4.89M	4.62M	6.14M			15.01M	15.54M
Inventory (Quarter)								9.72M	9.20M	10.37M	17.62M			51.52M	65.55M	49.83M	51.71M	51.68M	58.38M	55.59M
Prepaid Assets (Quarter)	6.58M	3.55M	7.78M	7.13M	9.71M	7.27M	11.49M	14.23M	12.02M	17.46M	11.49M			12.38M	15.89M	11.55M	9.82M	11.58M	12.93M	8.87M
Current Assets (Quarter)	583.03M	507.96M	489.97M	431.59M	369.88M	479.12M	637.78M	274.88M	382.59M	307.85M	385.53M			457.02M	512.65M	422.50M	429.09M	442.69M	466.50M	464.26M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	88.03M	100.94M	102.76M	101.15M	100.75M	105.23M	109.92M	112.55M	113.14M	114.03M	111.79M			109.08M	111.58M	122.47M	126.65M	131.11M	131.39M	131.46M
Long-Term Investments (Quarter)	78.25M	91.59M	27.70M
Intangibles (Quarter)								235.51M	223.61M	229.26M	294.30M		333.61M	282.40M	322.48M	296.25M	335.31M	335.16M	329.70M	330.24M
Goodwill & Intangibles (Quarter)								235.51M	223.61M	229.26M	294.30M		333.61M	282.40M	322.48M	296.25M	335.31M	335.16M	329.70M	330.24M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	6.08M	6.08M	6.08M	6.43M	6.43M	0.19M	6.43M	66.40M	0.28M	0.27M	6.40M			6.36M	0.43M	5.94M	9.27M	5.98M	8.29M	6.43M
Non-Current Assets (Quarter)	245.80M	269.38M	211.28M	179.28M	176.04M	184.87M	186.99M	482.42M	469.73M	472.50M	484.30M			453.41M	454.09M	484.94M	475.86M	470.48M	459.16M	451.27M
Assets (Quarter)	828.83M	777.33M	701.25M	610.88M	545.92M	663.98M	824.77M	757.29M	852.32M	780.35M	869.83M			910.43M	966.74M	907.44M	904.95M	913.17M	925.66M	915.53M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	12.18M	27.38M	20.45M	20.01M	24.25M	26.60M	31.57M	31.16M	19.27M	33.12M	25.70M			27.51M	28.49M	32.00M	31.24M	22.16M	37.45M	26.21M
Notes Payables (Quarter)															1.00M	1.00M	1.00M	1.00M	1.00M
Payables (Quarter)	12.18M	27.38M	20.45M	20.01M	24.25M	26.60M	31.57M	31.16M	19.27M	33.12M	25.70M			27.51M	29.49M	33.00M	32.24M	23.16M	38.45M	26.21M
Accumulated Expenses (Quarter)	45.97M	56.77M	48.91M	13.47M	47.82M	20.19M	43.09M	46.62M	28.82M	69.41M	46.44M			81.94M	84.70M	89.08M	87.27M	111.16M	88.07M	77.96M
Other Accumulated Expenses (Quarter)	2.36M	3.76M	2.77M	3.56M	5.41M	3.30M	4.29M	4.57M	4.28M	6.59M	3.98M
Short term Debt (Quarter)
Current Leases (Quarter)	6.62M	5.06M	7.71M	6.48M	7.17M	12.59M	12.61M	10.87M	10.47M	7.78M	11.08M			12.90M	8.50M	7.07M	6.28M	4.04M	2.90M	2.67M
Total Current Liabilities (Quarter)	64.77M	89.20M	77.08M	64.19M	79.25M	91.48M	87.27M	88.64M	90.95M	110.31M	83.21M			122.34M	122.69M	129.16M	125.78M	138.36M	129.42M	106.85M
Non-Current Liabilities
Non-Current Debt (Quarter)	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M			1.00M
Non-Current Deffered Revenue (Quarter)
Non-Current Deferred Tax Liability (Quarter)								20.24M	18.34M	17.35M	33.30M			32.31M	31.96M	34.70M	31.66M	31.83M	30.61M	29.31M
Operating Leases (Quarter)	64.73M	65.47M	71.18M	73.00M	71.94M	71.86M	69.61M	68.84M	68.01M	67.08M	72.29M			44.37M	44.22M	45.10M	45.21M	44.40M	43.88M	43.33M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)	65.73M	66.47M	72.18M	74.00M	72.94M	72.86M	70.61M	90.08M	87.35M	85.43M	106.59M			77.68M	76.18M	79.79M	76.88M	76.23M	74.49M	72.64M
Total Liabilities (Quarter)	130.50M	155.67M	149.26M	138.19M	152.19M	164.34M	157.89M	178.72M	178.31M	195.74M	189.81M			200.02M	198.88M	208.95M	202.66M	214.59M	203.91M	179.49M
Shareholder's Equity
Total Debt (Quarter)	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M			1.00M
Common Equity (Quarter)	698.33M	621.66M	551.99M	472.69M	393.74M	499.64M	666.88M	578.57M	674.01M	584.61M	680.02M	768.54M	773.46M	710.40M	767.87M	698.49M	702.29M	698.58M	721.75M	736.04M
Liabilities and Shareholders Equity (Quarter)	828.83M	777.33M	701.25M	610.88M	545.92M	663.98M	824.77M	757.29M	852.32M	780.35M	869.83M			910.43M	966.74M	907.44M	904.95M	913.17M	925.66M	915.53M
Retained Earnings (Quarter)	1,771.44M	-1172.44M	-1264.05M	-2.70M	-1463.02M	-0.90M	-1675.71M	2,360.47M	2,579.09M	2,594.45M	0.12M			3,095.99M	3,262.27M	3,289.99M	3,389.79M	3,457.65M	3,563.66M	3,624.84M
Preferred Shares (Quarter)	0.00M	0.00M			0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M			0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Treasury Shares (Quarter)	1.16M	1.11M	3.10M	2.50M	2.45M	2.44M	3.91M	4.15M	3.79M	3.45M	12.08M	11.84M	9.92M	9.55M	12.16M	11.41M	9.88M	9.08M	13.93M	12.71M

Research Tools

Datasets

Plans

Developers

Iovance Biotherapeutics Balance Sheet (2010-2026) | IOVA

Research Tools

Datasets

Plans

Developers

Iovance Biotherapeutics Balance Sheet (2010-2026) | IOVA

Create an account

Sign In

Reset Password